BusinessPhoto: Mint MarketsSudarshan Pharma Shares Rise 7% After NSE Main Board Listing
Sudarshan Pharma's shares jumped 7% on Wednesday following its migration from BSE’s SME platform to the NSE main board. The company's board will review Q2 FY27 results and consider a fundraising proposal on October 29. This move boosted investor confidence despite weak overall market trends on Dalal Street.
Mint Markets·

